Five Drugs Set For EU Approval, Including Two Orphans

 
• By Maureen Kenny

The EU’s CHMP has recommended approval of a number of products including Pfizer’s Mylotarg for acute myeloid leukemia, Ammtek’s Amglidia for neonatal diabetes, and BioCryst Pharmaceuticals/Seqirus’ Alpivab for uncomplicated influenza.

Yes, no, maybe
A number of products are awaiting a final approval decision in the EU • Source: Shutterstock

More from Approvals

More from Product Reviews